Chanvillard, Coralie <br/><br/>
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.  [electronic resource] 

 -  PloS one  2012 
 - e39625 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0039625  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>B-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cell Count<br/>Cell Differentiation--drug effects<br/>Cohort Studies<br/>Female<br/>Humans<br/>Killer Cells, Natural--drug effects<br/>Male<br/>Middle Aged<br/>Mitoxantrone--pharmacology<br/>Multiple Sclerosis, Chronic Progressive--drug therapy<br/>Neutrophils--drug effects